Vivo Capital
Finance · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
192 Lytton Ave, Palo Alto, California, 9...Phone Number
(650) 688-0818Website
www.vivocapital.comRevenue
$6.6 MillionIndustry
ZI Rank: 3
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
2
2
2
3
3
About Vivo Capital
Vivo Capital founded in 1996 and headquartered in Palo Alto, California, is a global healthcare investment firm focused on private and public equity as well as venture capital.Explore more
Vivo Capital Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vivo Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Vivo Capital recently announced quarterly report
Vivo Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Vivo Capital is spiking on competitors!
Funding: Get notified immidiatlly once Vivo Capital has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Vivo Capital
Website visits: Recent activity has been detected on your website
Click to see if Vivo Capital had a recent Job posting/layoffs
Check if Vivo Capital has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Vivo Capital launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Vivo Capital
Compare insights from companies similar to Vivo Capital, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vivo Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Vivo Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Vivo Capital.
Vivo Capital Tech Stack
A closer look at the technologies used by Vivo Capital
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Vivo Capital News & Media
Vivo Opportunity (CLNN) reports near‑9.99% holdings including warrants - Stock Titan
Vivo Opportunity entities report 1,886,469 shares and 127,420 shares in Clene Inc., each shown as 9.99%, including shares issuable on multiple warrants.Appeal Decision By Eastern Caribbean Supreme Court Supports Right of Prime Success and Vivo Capital to Participate in Critical Sinovac Biotech Shareholder Vote
PALO ALTO, Calif.--(BUSINESS WIRE)--Vivo Capital (“Vivo” or “we”), a leading global investment firm focused exclusively on healthcare and life sciences and a long term shareholder of Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), today announced that the Court of Appeals of the Eastern Caribbean Supreme Court granted a motion to stay the self-interested injunction sought and led by 1Globe to prevent legitimate, long-term shareholders in the Company from participating in its criUnited States District Court of Massachusetts Bars Activist 1Globe Capital and Jiaqiang Li From Making Further Materially Misleading Statements Regarding Sinovac
PALO ALTO, Calif.--(BUSINESS WIRE)--Vivo Capital (“Vivo” or “we”), a leading global investment firm focused exclusively on healthcare and life sciences and a long-term shareholder of Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), today announced that the United States District Court of Massachusetts (“the Court”) granted Vivo’s motion for a preliminary injunction against 1Globe Capital, LLC and its owner Jiaqiang “Chiang” Li (collectively, “1Globe”), barring 1Globe from makingVivo Capital Issues Letter to Sinovac Biotech Shareholders Addressing the Company’s False and Misleading Claims
PALO ALTO, Calif.--(BUSINESS WIRE)--Vivo Capital (“Vivo” or “we”), a leading global investment firm focused exclusively on healthcare and life sciences and an approximately 8% shareholder in Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), today sent a letter to shareholders. *** Dear Fellow Sinovac Shareholders, We, Vivo Capital (“Vivo”), write to you as fellow shareholders of Sinovac Biotech Ltd. (“Sinovac” or the “Company”) to address a number of statements in the April 29, 20
Read more news
Top Finance Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vivo Capital
Sign Up For FreeTo access detailed company insights
Vivo Capital founded in 1996 and headquartered in Palo Alto, California, is a global healthcare investment firm focused on private and public equity as well as venture capital.... Read More
